OneMedNet Corporation

OneMedNet Receives High Six-Figure Add-On Order Under Multiyear Agreement Announced September 30

OneMedNet received a high six-figure add-on order under the multiyear agreement announced September 30, 2026, with the customer exercising its expansion option to increase data volume by 150%. The customer, an AI-enabled precision medicine company, is using the licensed Real-World Data to train clinical and diagnostic models and to build a derivative dataset for its own channel; the structure retains potential recurring sublicensing revenue for OneMedNet. Management framed the repeat order within weeks of the original signing as evidence of demand for its first-party, regulatory decision-grade data from a network of more than 2,300 healthcare partner sites.

•13h ago

OneMedNet Signs Global Pharmaceutical Intelligence Provider as Channel Partner, Extending Reach in Pharma Market

OneMedNet signed its 12th channel-partner agreement, this time with a leading global pharmaceutical intelligence and data solutions provider that will distribute OneMedNet's U.S.-sourced, de-identified clinical data to pharma customers worldwide. The unnamed partner will pair OneMedNet's multimodal, direct-from-source clinical data with its own analytics to serve pharma clients across drug development, regulatory submissions, market access, and medical AI. The deal extends OneMedNet's commercial reach into the pharmaceutical market, which third-party research sizes at roughly $2.7 billion in 2026, projected to reach $7.1 billion by 2033. No financial terms of the agreement were disclosed.

•15d ago

OneMedNet Adds Leading Hospital System Provider Network, Expanding By Up to 12 Hospitals

OneMedNet added a leading hospital system to its iRWD™ platform and federated provider network, with expansion expected to reach up to 12 additional hospitals. The partnership deepens the company's direct-from-source, longitudinal real-world data covering multimodal imaging and complete patient journeys across therapy areas. Management frames the expansion as supporting both foundational AI model development and real-world evidence generation, though no financial terms were disclosed.

•19d ago

OneMedNet Signs Mediplexus as its 11th Channel Partner, Expanding the Company’s Real World Data Footprint into Korea and the Asia Pacific Region

OneMedNet signed Mediplexus, a subsidiary of Korean CRO C&R Research, as its 11th channel partner to distribute OneMedNet's U.S.-sourced Real World Data in Korea and the broader Asia Pacific region. The initial engagement runs one year, with plans to broaden scope in stages. Mediplexus will pair OneMedNet's data with analysis, model validation, and regulatory support to help Korean medtech and medical AI companies enter the U.S. market. OneMedNet's iRWD network now exceeds 90 million patient journeys, 270 million studies, and 2,300 healthcare partner sites, giving the partnership a large multimodal dataset to commercialize in a region projected to see the fastest RWE market growth.

•27d ago

OneMedNet Signs Seven Figure Multiyear Agreement to Power a Partner Sold Derivative Data Solution

OneMedNet signed a seven-figure multiyear agreement to supply de-identified, multimodal clinical Real World Data via its iRWD platform to an AI-enabled precision medicine company, its tenth channel partner. The customer will build a licensable derivative dataset combining its molecular data with OneMedNet's first-party imaging and clinical records, with OneMedNet earning recurring sublicensing revenue on each downstream end-customer license. The deal includes an option to expand data volume and contract value, and OneMedNet retains source-data rights — end customers may not relicense or resell the underlying data.

•1mo ago

Atropos Health Scales Federated Evidence Network with Multimodal Data Partners to Accelerate Health Analytics and AI Model Development

OneMedNet signed a new data partnership with Atropos Health as part of a major expansion of the Atropos Evidence Network, alongside deeper collaborations with Norstella and Arcadia. OneMedNet CEO Aaron Green framed the deal as transforming the company's regulatory decision-grade data into long-term subscription collaborations, consistent with its data-monetization strategy. The expanded network now covers over 330 million U.S. patients and 150 million+ EHR records; no financial terms were disclosed, so the revenue impact is unquantified.

•1mo ago

OneMedNet Reports Record Bookings as Faster Fulfillment Begins

OneMedNet reported year-to-date bookings of approximately $16.2 million, a 16X increase versus the same period in 2025, with a significant portion expected to be delivered during the remainder of the year. Roughly 50% of 2026 contracts are with new customers, while the existing base continues to expand through high reorder and follow-on engagement rates. Platform improvements have made order fulfillment approximately 50X faster, enabling larger orders and quicker delivery across a network of more than 2,300 healthcare partner sites, 90 million-plus patient journeys, and 270 million studies. Bookings are not revenue, and the release notes conversion depends on customer acceptance and delivery timing, so upcoming filings will show how much of this demand reaches the top line.

•1mo ago

OneMedNet’s iRWD Platform Enables Rapid Feasibility-to-Delivery for Leading AI-Driven Drug Development Company

OneMedNet signed an agreement to provide full-fidelity clinical Real-World Data to a leading AI-driven drug development company. The deal highlights the iRWD platform's speed, achieving cohort feasibility in minutes, validation in a week, and contracting within three weeks. OneMedNet's network now spans over 2,300 healthcare sites, 90 million patient journeys, and 270 million studies.

•2mo ago

OneMedNet Secures $11.5+ Million Agreement to Supply Regulatory-Grade Real-World Data for Foundational AI Model Development

OneMedNet announced an agreement valued at over $11.5 million to supply regulatory-grade, multi-modal imaging data for the training of a foundational AI model. The contract includes the immediate delivery of de-identified medical imaging and clinical reports, leveraging the company's secure federated network. This agreement expands on the company's commercial momentum, utilizing a network that now encompasses over 90 million patient journeys across more than 2,300 healthcare sites.

•3mo ago

OneMedNet Executes on Growth Strategy: Secures Over $3 Million in New Bookings, Surpassing Full-Year 2025

OneMedNet secured more than $3 million in new bookings for 2026 in just over five months, surpassing its total bookings for all of 2025. The company expects to recognize substantially all of these bookings as revenue by the end of the third quarter of 2026, demonstrating rapid conversion from contract to cash. This momentum is driven by the iRWD™ Platform, powered by Palantir Foundry, which is seeing increased adoption for regulatory submissions and AI model development across a network of 2,300+ healthcare sites.

•4mo ago

OneMedNet Surpasses 90 Million Patient Journeys and 270 Million Studies within its Network

OneMedNet announced its iRWD™ Network has surpassed 90 million patient journeys and 270 million studies, with a healthcare partner network exceeding 2,300 sites. The patient journey count rose 12.5% in just two months since April 2026, while the provider network expanded by more than 30% in less than a year from approximately 1,750 sites. CEO Aaron Green stated the milestone reflects disciplined execution against the strategic priorities outlined to shareholders at the close of 2025, emphasizing the growing demand for Real-World Data and AI foundational models.

•5mo ago

OneMedNet Goes Live with 80 Million Patient Journeys and Billions of Records

OneMedNet announced its iRWD Platform, built on Palantir Foundry, is now live and fully operational, offering searchable access to billions of records across 80 million patient journeys. The network has expanded by approximately 70% to 251 million studies and enables linkage to 47 million tokenized patients via Datavant, creating what the company believes is the industry's largest curated multi-modal Real-World Data network. Two new customers have already been contracted for the platform as the company focuses on converting its pipeline into high-margin annual recurring revenue subscriptions.

•6mo ago